Abstract: Provided is designer nucleic acid constructs and polypeptides that can be used as therapeutic vaccines against HPV16.

Abstract: A poliovirus (PV) strain was attenuated by a novel method of Cold-Adapted-Viral-Attenuation (CAVA). The resulting recombinant attenuated PV, CAVA-PV, shows wild-type replication at 30° C., but no substantial replication at 37° C. The inability to replicate at 37° C. is defined by an inability to quantify virus during infection at this temperature by titration (infectious units), qPCR (viral RNA) or Electron Microscopy (visual signs of infection). CAVA-PV is genetically stable under production conditions and shows utility for use as the backbone to produce attenuated strains with the same antigenic profile as conventional vaccines by replacing the sequence coding for the capsid of CAVA-PV with sequences coding for capsids of different PV strains. Furthermore, mutations identified in CAVA-PV can be engineered into different, even wild-type and neurovirulent poliovirus background strains to obtain additional CAVA-PV strains.

Abstract: Provided is designer nucleic acid constructs and polypeptides that can be used as therapeutic vaccines against HPV18 and/or HPV16.

Abstract: Provided is designer nucleic acid constructs and polypeptides that can be used as therapeutic vaccines against HPV16.

Abstract: The present invention provides predominantly callus-specific promoters obtainable from Brassica napus plants. According to the present invention there is provided a DNA fragment harbouring a callus specific promoter, said DNA fragment being present in clone pJB1178-21 or clone pJB1178-43, respectively deposited with the Centraal Bureau of Schimmelcultures (Baarn, the Netherlands) on 6 Feb. 2001 under no. CBS 109271 and no. CBS 109273. The DNA fragment according to the present invention is further characterised in that it comprises the nucleotide sequence represented by SEQ ID NO: 1 or SEQ ID NO: 2 or the full length sequences as depicted in SEQ ID NO: 8 or SEQ ID NO: 9 respectively or parts thereof. Further, the invention comprises the homologue sequences in Arabidopsis thaliana as depicted in SEQ ID NO: 10 and SEQ ID NO: 11, respectively.

Abstract: The present invention provides predominantly callus-specific promoters obtainable from Brassica napus plants. According to the present invention there is provided a DNA fragment harbouring a callus specific promoter, said DNA fragment being present in clone pJB1178-21 or clone pJB1178-43, respectively deposited with the Centraal Bureau of Schimmelcultures (Baarn, the Netherlands) on 6 Feb. 2001 under no. CBS 109271 and no. CBS 109273. The DNA fragment according to the present invention is further characterised in that it comprises the nucleotide sequence represented by SEQ ID NO: 1 or SEQ ID NO: 2 or the full length sequences as depicted in SEQ ID NO: 8 or SEQ ID NO: 9 respectively or parts thereof. Further, the invention comprises the homologue sequences in Arabidopsis thaliana as depicted in SEQ ID NO: 10 and SEQ ID NO: 11, respectively.

Abstract: The present invention provides a constitutive promoter obtainable from Brassica napus plants. According to the present invention there is provided aDNA fragment harbouring a constitutive promoter, said DNA fragment being present in clone pJB1178-29, deposited with the Centraal Bureau of Schimmelcultures (Baarn, the Nederlands) on 6 Feb. 2001 under no. CBS 109272. The DNA fragment according to the present invention is further characterised in that it comprises whole or parts of the sequence represented by SEQ ID NO: 7. Further, the invention comprises the homologue sequence in Arabidopsis thaliana as depicted in SEQ ID NO:8.

Abstract: The invention comprises a method for the induction of pathogen resistance in plants characterized by transforming a plant with a polynucleotide sequence comprising a pathogen inducible promoter which regulates the expression of a plant signal transduction protein or a homologue thereof which when constitutively expressed gives rise to a hypersensitive response in plants. Alternatively, the invention comprises a method for the induction of pathogen resistance in plants characterized by transforming a plant with a polynucleotide sequence comprising a pathogen inducible promoter which regulates the expression of a compound which is able to alleviate the inhibitory effect of a protein on the signal transduction pathway leading to a hypersensitive response in plants.

Abstract: This invention describes pathogen-inducible promoters which normally drive expression of plant hexose oxidases, especially those which can be isolated from Helianthus annuus and Lactuca sativa, more specifically those promoters which naturally are the regulatory regions driving expression of the hexose oxidase MS59 and WL64, respectively. Also claimed are chimeric constructs where these pathogen-inducible promoters drive expression of antipathogenic proteins or of proteins which can elicit a hypersensitive response.